Annual EBITDA
-$235.87 M
-$2.79 M-1.20%
31 December 2023
Summary:
Ionis Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization is currently -$235.87 million, with the most recent change of -$2.79 million (-1.20%) on 31 December 2023. During the last 3 years, it has fallen by -$124.68 million (-112.13%). IONS annual EBITDA is now -164.23% below its all-time high of $367.20 million, reached on 31 December 2019.IONS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$117.38 M
-$79.54 M-210.22%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization is currently -$117.38 million, with the most recent change of -$79.54 million (-210.22%) on 30 September 2024. Over the past year, it has dropped by -$2.54 million (-2.21%). IONS quarterly EBITDA is now -150.88% below its all-time high of $230.70 million, reached on 31 December 2021.IONS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$248.03 M
-$2.54 M-1.03%
30 September 2024
Summary:
Ionis Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization is currently -$248.03 million, with the most recent change of -$2.54 million (-1.03%) on 30 September 2024. Over the past year, it has increased by +$47.03 million (+15.94%). IONS TTM EBITDA is now -167.55% below its all-time high of $367.20 million, reached on 31 December 2019.IONS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.2% | -2.2% | +15.9% |
| 3 y3 years | -112.1% | -50.2% | -0.4% |
| 5 y5 years | -1152.0% | -711.3% | -236.6% |
IONS EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4446.4% | at low | -150.9% | at low | -818.0% | +15.9% |
| 5 y | 5 years | -164.2% | at low | -150.9% | at low | -167.6% | +15.9% |
| alltime | all time | -164.2% | at low | -150.9% | at low | -167.6% | +15.9% |
Ionis Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$117.38 M(+210.2%) | -$248.03 M(+1.0%) |
| June 2024 | - | -$37.84 M(-67.5%) | -$245.50 M(-5.4%) |
| Mar 2024 | - | -$116.52 M(-591.8%) | -$259.48 M(+10.7%) |
| Dec 2023 | -$235.87 M(+1.2%) | $23.69 M(-120.6%) | -$234.47 M(-20.5%) |
| Sept 2023 | - | -$114.84 M(+121.6%) | -$295.07 M(+33.5%) |
| June 2023 | - | -$51.81 M(-43.4%) | -$221.04 M(-17.0%) |
| Mar 2023 | - | -$91.51 M(+148.0%) | -$266.22 M(+14.2%) |
| Dec 2022 | -$233.08 M(+4392.7%) | -$36.90 M(-9.6%) | -$233.06 M(-774.7%) |
| Sept 2022 | - | -$40.81 M(-57.9%) | $34.54 M(-1329.7%) |
| June 2022 | - | -$96.99 M(+66.2%) | -$2.81 M(-114.3%) |
| Mar 2022 | - | -$58.35 M(-125.3%) | $19.65 M(-464.9%) |
| Dec 2021 | -$5.19 M(-95.3%) | $230.70 M(-395.1%) | -$5.38 M(-97.8%) |
| Sept 2021 | - | -$78.17 M(+4.9%) | -$246.97 M(+27.7%) |
| June 2021 | - | -$74.53 M(-10.6%) | -$193.47 M(+30.8%) |
| Mar 2021 | - | -$83.38 M(+666.1%) | -$147.94 M(+32.2%) |
| Dec 2020 | -$111.19 M(-130.3%) | -$10.88 M(-55.9%) | -$111.90 M(-201.4%) |
| Sept 2020 | - | -$24.67 M(-14.9%) | $110.36 M(-28.4%) |
| June 2020 | - | -$29.00 M(-38.7%) | $154.22 M(-15.4%) |
| Mar 2020 | - | -$47.34 M(-122.4%) | $182.31 M(-50.4%) |
| Dec 2019 | $367.20 M(-2049.1%) | $211.37 M(+1000.9%) | $367.20 M(+102.2%) |
| Sept 2019 | - | $19.20 M(-2187.0%) | $181.57 M(+15.7%) |
| June 2019 | - | -$920.00 K(-100.7%) | $157.00 M(+35.6%) |
| Mar 2019 | - | $137.55 M(+434.3%) | $115.77 M(-714.6%) |
| Dec 2018 | -$18.84 M(-151.8%) | $25.75 M(-578.7%) | -$18.84 M(-61.7%) |
| Sept 2018 | - | -$5.38 M(-87.2%) | -$49.13 M(+33.2%) |
| June 2018 | - | -$42.15 M(-1530.3%) | -$36.90 M(-322.5%) |
| Mar 2018 | - | $2.95 M(-164.8%) | $16.59 M(-54.4%) |
| Dec 2017 | $36.34 M(-477.0%) | -$4.55 M(-166.4%) | $36.34 M(-66.4%) |
| Sept 2017 | - | $6.86 M(-39.5%) | $108.05 M(-10.4%) |
| June 2017 | - | $11.33 M(-50.1%) | $120.56 M(+88.3%) |
| Mar 2017 | - | $22.70 M(-66.2%) | $64.04 M(-764.4%) |
| Dec 2016 | -$9.64 M(-76.5%) | $67.16 M(+246.7%) | -$9.64 M(-92.9%) |
| Sept 2016 | - | $19.37 M(-142.9%) | -$135.88 M(-24.2%) |
| June 2016 | - | -$45.19 M(-11.4%) | -$179.17 M(+108.9%) |
| Mar 2016 | - | -$50.98 M(-13.7%) | -$85.78 M(+109.5%) |
| Dec 2015 | -$40.94 M(+79.7%) | -$59.08 M(+146.9%) | -$40.94 M(-194.2%) |
| Sept 2015 | - | -$23.93 M(-149.6%) | $43.45 M(-12.2%) |
| June 2015 | - | $48.20 M(-886.0%) | $49.52 M(-2010.5%) |
| Mar 2015 | - | -$6.13 M(-124.2%) | -$2.59 M(-88.6%) |
| Dec 2014 | -$22.78 M(-39.1%) | $25.31 M(-241.7%) | -$22.78 M(-64.7%) |
| Sept 2014 | - | -$17.86 M(+356.9%) | -$64.59 M(-6.7%) |
| June 2014 | - | -$3.91 M(-85.1%) | -$69.22 M(-0.2%) |
| Mar 2014 | - | -$26.32 M(+59.5%) | -$69.36 M(+85.3%) |
| Dec 2013 | -$37.42 M(-12.3%) | -$16.50 M(-26.6%) | -$37.42 M(+37.9%) |
| Sept 2013 | - | -$22.49 M(+455.3%) | -$27.14 M(-26.8%) |
| June 2013 | - | -$4.05 M(-172.1%) | -$37.06 M(+27.8%) |
| Mar 2013 | - | $5.62 M(-190.3%) | -$29.00 M(-45.7%) |
| Dec 2012 | -$42.68 M(-24.2%) | -$6.22 M(-80.8%) | -$53.44 M(-14.0%) |
| Sept 2012 | - | -$32.41 M(-907.8%) | -$62.14 M(+19.9%) |
| June 2012 | - | $4.01 M(-121.3%) | -$51.84 M(-26.3%) |
| Mar 2012 | - | -$18.81 M(+26.0%) | -$70.29 M(+3.3%) |
| Dec 2011 | -$56.27 M(+45.2%) | -$14.93 M(-32.5%) | -$68.06 M(+7.0%) |
| Sept 2011 | - | -$22.11 M(+53.1%) | -$63.63 M(+25.7%) |
| June 2011 | - | -$14.44 M(-12.9%) | -$50.63 M(-12.8%) |
| Mar 2011 | - | -$16.58 M(+57.9%) | -$58.08 M(+21.2%) |
| Dec 2010 | -$38.75 M(+295.8%) | -$10.50 M(+15.2%) | -$47.93 M(-1.6%) |
| Sept 2010 | - | -$9.12 M(-58.4%) | -$48.69 M(+0.6%) |
| June 2010 | - | -$21.89 M(+240.9%) | -$48.42 M(+78.9%) |
| Mar 2010 | - | -$6.42 M(-43.0%) | -$27.06 M(+41.7%) |
| Dec 2009 | -$9.79 M(-338.2%) | -$11.26 M(+27.4%) | -$19.09 M(+33.0%) |
| Sept 2009 | - | -$8.84 M(+1546.7%) | -$14.36 M(+667.8%) |
| June 2009 | - | -$537.00 K(-134.6%) | -$1.87 M(-191.2%) |
| Mar 2009 | - | $1.55 M(-123.7%) | $2.05 M(-175.8%) |
| Dec 2008 | $4.11 M(-115.7%) | -$6.53 M(-279.1%) | -$2.71 M(-292.3%) |
| Sept 2008 | - | $3.64 M(+7.7%) | $1.41 M(-82.0%) |
| June 2008 | - | $3.38 M(-205.5%) | $7.82 M(-151.4%) |
| Mar 2008 | - | -$3.21 M(+32.8%) | -$15.22 M(-53.8%) |
| Dec 2007 | -$26.15 M | -$2.41 M(-124.0%) | -$32.92 M(-25.9%) |
| Sept 2007 | - | $10.06 M(-151.2%) | -$44.42 M(-39.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | -$19.66 M(-5.9%) | -$73.02 M(+3.3%) |
| Mar 2007 | - | -$20.90 M(+50.2%) | -$70.68 M(+7.5%) |
| Dec 2006 | -$58.54 M(+46.9%) | -$13.91 M(-25.0%) | -$65.75 M(+8.0%) |
| Sept 2006 | - | -$18.54 M(+7.1%) | -$60.87 M(+11.0%) |
| June 2006 | - | -$17.32 M(+8.4%) | -$54.82 M(+10.1%) |
| Mar 2006 | - | -$15.98 M(+76.9%) | -$49.78 M(-0.9%) |
| Dec 2005 | -$39.84 M(-45.6%) | -$9.03 M(-27.7%) | -$50.22 M(-17.1%) |
| Sept 2005 | - | -$12.49 M(+1.8%) | -$60.56 M(-14.0%) |
| June 2005 | - | -$12.27 M(-25.3%) | -$70.45 M(-11.4%) |
| Mar 2005 | - | -$16.42 M(-15.2%) | -$79.51 M(-6.9%) |
| Dec 2004 | -$73.26 M(+12.8%) | -$19.37 M(-13.4%) | -$85.43 M(-2.4%) |
| Sept 2004 | - | -$22.38 M(+4.9%) | -$87.53 M(+3.9%) |
| June 2004 | - | -$21.34 M(-4.5%) | -$84.22 M(+4.5%) |
| Mar 2004 | - | -$22.34 M(+4.0%) | -$80.60 M(+4.4%) |
| Dec 2003 | -$64.92 M(+62.2%) | -$21.48 M(+12.7%) | -$77.18 M(+17.7%) |
| Sept 2003 | - | -$19.07 M(+7.6%) | -$65.57 M(+2.4%) |
| June 2003 | - | -$17.72 M(-6.3%) | -$64.01 M(+9.2%) |
| Mar 2003 | - | -$18.91 M(+91.6%) | -$58.63 M(+18.6%) |
| Dec 2002 | -$40.02 M(+2.3%) | -$9.87 M(-43.6%) | -$49.44 M(+4.6%) |
| Sept 2002 | - | -$17.51 M(+41.9%) | -$47.26 M(+37.1%) |
| June 2002 | - | -$12.34 M(+27.0%) | -$34.46 M(-10.7%) |
| Mar 2002 | - | -$9.72 M(+26.3%) | -$38.59 M(-16.3%) |
| Dec 2001 | -$39.13 M(+66.9%) | -$7.70 M(+63.5%) | -$46.10 M(-4.8%) |
| Sept 2001 | - | -$4.71 M(-71.4%) | -$48.42 M(+11.3%) |
| June 2001 | - | -$16.46 M(-4.5%) | -$43.50 M(+23.5%) |
| Mar 2001 | - | -$17.23 M(+72.1%) | -$35.22 M(+21.5%) |
| Dec 2000 | -$23.45 M(-38.1%) | -$10.01 M(-4960.2%) | -$28.99 M(-7.9%) |
| Sept 2000 | - | $206.00 K(-102.5%) | -$31.48 M(-20.9%) |
| June 2000 | - | -$8.18 M(-25.7%) | -$39.78 M(-8.8%) |
| Mar 2000 | - | -$11.01 M(-11.9%) | -$43.61 M(+1.2%) |
| Dec 1999 | -$37.90 M(+34.4%) | -$12.50 M(+54.3%) | -$43.10 M(+6.9%) |
| Sept 1999 | - | -$8.10 M(-32.5%) | -$40.30 M(+29.6%) |
| June 1999 | - | -$12.00 M(+14.3%) | -$31.10 M(-3.1%) |
| Mar 1999 | - | -$10.50 M(+8.2%) | -$32.10 M(-1.5%) |
| Dec 1998 | -$28.20 M(+0.4%) | -$9.70 M(-981.8%) | -$32.60 M(-1.8%) |
| Sept 1998 | - | $1.10 M(-108.5%) | -$33.20 M(-10.0%) |
| June 1998 | - | -$13.00 M(+18.2%) | -$36.90 M(+9.8%) |
| Mar 1998 | - | -$11.00 M(+6.8%) | -$33.60 M(+6.7%) |
| Dec 1997 | -$28.10 M(+6.0%) | -$10.30 M(+296.2%) | -$31.50 M(+2.6%) |
| Sept 1997 | - | -$2.60 M(-73.2%) | -$30.70 M(-11.8%) |
| June 1997 | - | -$9.70 M(+9.0%) | -$34.80 M(+4.8%) |
| Mar 1997 | - | -$8.90 M(-6.3%) | -$33.20 M(+14.1%) |
| Dec 1996 | -$26.50 M(+16.2%) | -$9.50 M(+41.8%) | -$29.10 M(+12.8%) |
| Sept 1996 | - | -$6.70 M(-17.3%) | -$25.80 M(-2.6%) |
| June 1996 | - | -$8.10 M(+68.8%) | -$26.50 M(+8.6%) |
| Mar 1996 | - | -$4.80 M(-22.6%) | -$24.40 M(-5.1%) |
| Dec 1995 | -$22.80 M(+22.6%) | -$6.20 M(-16.2%) | -$25.70 M(-16.3%) |
| Sept 1995 | - | -$7.40 M(+23.3%) | -$30.70 M(+8.5%) |
| June 1995 | - | -$6.00 M(-1.6%) | -$28.30 M(+4.4%) |
| Mar 1995 | - | -$6.10 M(-45.5%) | -$27.10 M(+6.3%) |
| Dec 1994 | -$18.60 M(+23.2%) | -$11.20 M(+124.0%) | -$25.50 M(+36.4%) |
| Sept 1994 | - | -$5.00 M(+4.2%) | -$18.70 M(+3.3%) |
| June 1994 | - | -$4.80 M(+6.7%) | -$18.10 M(+1.1%) |
| Mar 1994 | - | -$4.50 M(+2.3%) | -$17.90 M(-3.2%) |
| Dec 1993 | -$15.10 M(-23.0%) | -$4.40 M(0.0%) | -$18.50 M(-11.5%) |
| Sept 1993 | - | -$4.40 M(-4.3%) | -$20.90 M(+0.5%) |
| June 1993 | - | -$4.60 M(-9.8%) | -$20.80 M(+4.5%) |
| Mar 1993 | - | -$5.10 M(-25.0%) | -$19.90 M(+2.1%) |
| Dec 1992 | -$19.60 M(+104.2%) | -$6.80 M(+58.1%) | -$19.50 M(+11.4%) |
| Sept 1992 | - | -$4.30 M(+16.2%) | -$17.50 M(+15.1%) |
| June 1992 | - | -$3.70 M(-21.3%) | -$15.20 M(+11.8%) |
| Mar 1992 | - | -$4.70 M(-2.1%) | -$13.60 M(+34.7%) |
| Dec 1991 | -$9.60 M(+134.1%) | -$4.80 M(+140.0%) | -$10.10 M(-10.6%) |
| Sept 1991 | - | -$2.00 M(-4.8%) | -$11.30 M(+28.4%) |
| June 1991 | - | -$2.10 M(+75.0%) | -$8.80 M(+41.9%) |
| Mar 1991 | - | -$1.20 M(-80.0%) | -$6.20 M(+37.8%) |
| Dec 1990 | -$4.10 M | -$6.00 M(-1300.0%) | -$4.50 M(-400.0%) |
| Sept 1990 | - | $500.00 K(0.0%) | $1.50 M(+50.0%) |
| June 1990 | - | $500.00 K(0.0%) | $1.00 M(+100.0%) |
| Mar 1990 | - | $500.00 K | $500.00 K |
FAQ
- What is Ionis Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual EBITDA year-on-year change?
- What is Ionis Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Ionis Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals TTM EBITDA year-on-year change?
What is Ionis Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of IONS is -$235.87 M
What is the all time high annual EBITDA for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is $367.20 M
What is Ionis Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, IONS annual earnings before interest, taxes, depreciation & amortization has changed by -$2.79 M (-1.20%)
What is Ionis Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of IONS is -$117.38 M
What is the all time high quarterly EBITDA for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is $230.70 M
What is Ionis Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, IONS quarterly earnings before interest, taxes, depreciation & amortization has changed by -$2.54 M (-2.21%)
What is Ionis Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of IONS is -$248.03 M
What is the all time high TTM EBITDA for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is $367.20 M
What is Ionis Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, IONS TTM earnings before interest, taxes, depreciation & amortization has changed by +$47.03 M (+15.94%)